|
Volumn 27, Issue 6, 2013, Pages 425-432
|
Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography
|
Author keywords
Bevacizumab; Drug resistance; Macular degeneration; Optical coherence tomography; Ranibizumab
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
VASCULOTROPIN A;
AGED;
ANTAGONISTS AND INHIBITORS;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
METABOLISM;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOLOGY;
PROCEDURES;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
VERY ELDERLY;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FUNDUS OCULI;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
|
EID: 84927171369
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2013.27.6.425 Document Type: Article |
Times cited : (19)
|
References (0)
|